Results 21 to 30 of about 678,205 (261)

Lin−CCR2+ hematopoietic stem and progenitor cells overcome resistance to PD-1 blockade

open access: yesNature Communications, 2018
Brain tumors are difficult to treat using existing immunotherapeutic strategies. Here, the authors show that in brain tumors resistant to PD-1 blockade, HSCs expressing CCR2+ can reverse treatment resistance and sensitizes mice to immunotherapy.
Catherine T. Flores   +6 more
doaj   +1 more source

Clinical evaluation of a dedicated next generation sequencing panel for routine glioma diagnostics

open access: yesActa Neuropathologica Communications, 2018
Since 2013 next-generation sequencing (NGS) targeting genes mutated in diffuse gliomas is part of routine diagnostics in our institute. In the present report, we evaluate the use of this custom tailored NGS platform on 434 samples. The NGS panel assesses
Nathalie E. Synhaeve   +8 more
doaj   +1 more source

BRAIN TUMORS. [PDF]

open access: yesJournal of the American Medical Association, 1886
n ...
openaire   +2 more sources

Integrated genomic analyses of de novo pathways underlying atypical meningiomas

open access: yesNature Communications, 2017
Meningiomas are mostly benign brain tumours with the potential for becoming atypical or malignant. Here, the authors show that primary atypical meningiomas are epigenetically and genetically distinct from benign and progressed tumours, highlighting ...
Akdes Serin Harmancı   +26 more
doaj   +1 more source

Malignant Progression Contributes to the Failure of Combination Therapy for Atypical Meningiomas

open access: yesFrontiers in Oncology, 2021
ObjectiveTo investigate the independent risk factors for recurrence in intracranial atypical meningiomas (AMs) treated with gross total resection (GTR) and early external beam radiotherapy (EBRT).MethodsClinical, radiological, and pathological data of ...
Qing Zhang   +40 more
doaj   +1 more source

Brain Tumors [PDF]

open access: yesActa Oncologica, 1996
This synthesis of the literature on radiotherapy for brain tumors, ie, cancer originating in the central nervous system (CNS), is based on 81 scientific articles, including 25 randomized studies, 13 prospective studies, and 25 retrospective studies. These studies involve 11,081 patients.
openaire   +2 more sources

Central Nervous System Tumors Among Infants in Canada: A Report From CYP‐C

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Background Central nervous system (CNS) tumors in infants are rare, pose unique clinical challenges, and lack large‐scale evidence‐based data to guide management. This study seeks to describe CNS tumors in Canadian infants and to compare their outcomes with those of older children.
Samuel Sassine   +17 more
wiley   +1 more source

Autonomic modulation of the immune response and implications for CNS malignancies

open access: yesnpj Precision Oncology
While the central nervous system (CNS) has long been known to regulate global physiologic processes, its role in regulating immune responses has only relatively recently been appreciated.
Lucas P. Wachsmuth   +5 more
doaj   +1 more source

Classification of Progression Patterns in Glioblastoma: Analysis of Predictive Factors and Clinical Implications

open access: yesFrontiers in Oncology, 2020
BackgroundThis study was designed to explore the progression patterns of IDH-wildtype glioblastoma (GBM) at first recurrence after chemoradiotherapy.MethodsRecords from 247 patients who underwent progression after diagnosis of IDH-wildtype GBM was ...
Haihui Jiang   +14 more
doaj   +1 more source

Impact of Radiation Therapy on Physical and Psychosocial Health of Adolescents and Young Adults: A Joint Report From the Children's Oncology Group AYA and Radiation Oncology Committees

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Rates of cancer among adolescents and young adults (AYA), age 15–39 years, are increasing. Consequently, radiation oncologists are treating more AYAs who have diagnoses spanning both pediatric and adult practices. Compared to pediatric and older adult patients, AYAs face a unique set of challenges.
Hesham Elhalawani   +7 more
wiley   +1 more source

Home - About - Disclaimer - Privacy